Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant-Reference-Cited by-同舟云学术

Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant

Published:2020-11 Issue:4 Volume: Page:466-471
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Tramontana Timothy F.¹,Marshall Mark S.²,Helvie Amy E.²,Schmitt Morgan R.²,Ivanovich Jennifer¹,Carter Jacquelyn L.²,Renbarger Jamie L.²,Ferguson Michael J.²

Affiliation:

1. Department of Genetics, Indiana University School of Medicine, Indianapolis, IN

2. Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.19.00258

Reference28 articles.

1. Cytogenetic characterization of selected small round cell tumors of childhood

2. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22)(q24;q12)

3. EWS-FLI1 and EWS-ERG Gene Fusions Are Associated With Similar Clinical Phenotypes in Ewing's Sarcoma

4. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Report of a Rare Case of BCOR (B-cell Line 6 Corepressor)-Altered Sarcoma of the Lung in a Child;Cureus;2024-05-06

2. A Comprehensive Analysis of Clinical, Biochemical, and Polysomnographic Characteristics in Patients With Type 2 Diabetes Mellitus With and Without Obstructive Sleep Apnea;Cureus;2024-05-06

3. A rare presentation of round cell sarcoma;Current Problems in Cancer: Case Reports;2023-06

4. A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl);European Journal of Cancer;2023-04

5. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16